Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit A-site decoding center is a fundamental functional region within the small ribosomal subunit responsible for ensuring the accuracy of protein synthesis. It is primarily composed of the 16S ribosomal RNA (rRNA), where highly conserved nucleotides, specifically A1492 and A1493, monitor the fidelity of the codon-anticodon interaction between mRNA and aminoacyl-tRNA (Vicens & Westhof, 2001, PMID: 11130709). This site serves as a major therapeutic target for several classes of antibiotics, including aminoglycosides and tetracyclines. Aminoglycosides bind to the decoding center and stabilize an 'active' conformation of the rRNA, which forces the ribosome to accept near-cognate tRNAs, leading to the production of mistranslated, toxic proteins and subsequent bacterial cell death (Carter et al., 2000, PMID: 10591205). In contrast, tetracyclines bind to the A-site to physically block the entry of aminoacyl-tRNA, thereby halting the elongation phase of translation (Brodersen et al., 2000, PMID: 11130710). Because the structural features of the bacterial A-site differ significantly from the eukaryotic 40S subunit, these drugs exhibit selective toxicity against pathogens. Understanding the molecular architecture of this decoding center is critical for overcoming antibiotic resistance mechanisms, such as rRNA methylation or target site mutations.
Inhibition of protein synthesis via induction of mRNA misreading (mistranslation) or steric blockade of aminoacyl-tRNA binding to the A-site.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit A-site decoding center (30S A-site).